EcoDrugPlus

Dopamine Receptor D2

Ensembl ID : ENSSTUG00000003261
Gene Symbol: DRD2
3 Cross references
203 Possible Orthologues:

Dopamine Receptor D5

Ensembl ID : ENSSTUG00000044807
Gene Symbol: DRD5
1 Cross references
141 Possible Orthologues:

Dopamine Receptor D5

Ensembl ID : ENSSTUG00000047536
Gene Symbol: DRD5
3 Cross references
141 Possible Orthologues:

Dual Specificity Mitogen-Activated Protein Kinase Kinase 2

Ensembl ID : ENSSTUG00000048587
Gene Symbol: LOC115158253
3 Cross references
206 Possible Orthologues:

Dual Specificity Mitogen-Activated Protein Kinase Kinase 2-Like

Ensembl ID : ENSSTUG00000040895
Gene Symbol: LOC115157409
3 Cross references
194 Possible Orthologues:

Dual Specificity Mitogen-Activated Protein Kinase Kinase 2-Like

Ensembl ID : ENSSTUG00000005571
Gene Symbol: LOC115192626
3 Cross references
207 Possible Orthologues:

Dual Specificity Mitogen-Activated Protein Kinase Kinase 2-Like

Ensembl ID : ENSSTUG00000016240
Gene Symbol: LOC115169411
3 Cross references
194 Possible Orthologues:

Dual Specificity Protein Kinase Ttk-Like

Ensembl ID : ENSSTUG00000000884
Gene Symbol: LOC115175934
3 Cross references
197 Possible Orthologues:

Dual Specificity Protein Kinase Ttk-Like

Ensembl ID : ENSSTUG00000043393
Gene Symbol: LOC115177371
3 Cross references
198 Possible Orthologues:

Duodenase-1-Like

Ensembl ID : ENSSTUG00000011404
Gene Symbol: LOC115151806
2 Cross references
988 Possible Orthologues:

Echinoderm Microtubule-Associated Protein-Like 4

Ensembl ID : ENSSTUG00000000360
Gene Symbol: LOC115193916
2 Cross references
200 Possible Orthologues:

Ectonucleotide Pyrophosphatase/phosphodiesterase 2

Ensembl ID : ENSSTUG00000024922
Gene Symbol: ENPP2
3 Cross references
221 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).